Zhang, P., Wang, D., He, W., Zhang, H., Dong, Y., Situ, Y., Wang, M., Zhang, Y., Wei, S., Qiu, B., Huang, Y., Liu, H.

Toripalimab consolidation after chemoradiotherapy in limited-stage small cell lung cancer: a phase II, randomized controlled study (GASTO-1052A)

1 de October de 2026 by Zhang, P., Wang, D., He, W., Zhang, H., Dong, Y., Situ, Y., Wang, M., Zhang, Y., Wei, S., Qiu, B., Huang, Y., Liu, H.

Background
Immune-checkpoint inhibitors (ICIs) plus chemotherapy have demonstrated survival benefits in extensive-stage small cell lung cancer (SCLC). The integration of immunotherapy with concurrent chemoradiotherapy (CCRT) may improve survival outco…